Tech Company Financing Transactions

BioStratum Incorporated Funding Round

On 12/31/2011, BioStratum Incorporated raised $294 thousand in funding from private investors.

Transaction Overview

Announced On
12/31/2011
Transaction Type
Venture Equity
Amount
$294,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4825 Creekstone Dr. G
Durham, NC 27703
USA
Email Address
Not Recorded
Overview
BioStratum is a world leader in basal lamina research. The Company's research has identified a wealth of new therapeutic targets and drug candidates for preventing or treating kidney disease, cancer, and autoimmune diseases all of which currently lack effective treatments.
Profile
BioStratum Incorporated LinkedIn Company Profile
Social Media
BioStratum Incorporated Company Twitter Account
Company News
BioStratum Incorporated News
Facebook
BioStratum Incorporated on Facebook
YouTube
BioStratum Incorporated on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eugen Steiner
  Eugen Steiner LinkedIn Profile  Eugen Steiner Twitter Account  Eugen Steiner News  Eugen Steiner on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2011: StartDate Labs venture capital transaction
Next: 12/31/2011: Virxsys venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary